Ryman Healthcare downgraded to underweight from neutral at Jarden (NZ$2.91, 0.00)
StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday
Ryman Healthcare confirms intention to dual list on the ASX on 1-Oct (NZ$2.35, 0.00)
Ryman Healthcare expecting to list on the ASX in September (NZ$2.41, -0.05)
Insider transaction: Ryman Healthcare CEO & CFO disclose on market share purchases (NZ$2.60, 0.00)
Powered by FactSet Research Systems Inc.